Kite Pharma is hoping to connect with potential CAR-T patients using friendly graphics and easy-to-understand explanations.
Gilead's Kite clues patients in with conversational CAR-T cell therapy campaign
The problem with marketing a novel therapy is that it’s novel. Add a niche patient population and complex science and the challenge only grows. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
